Nuclear Medicine or Radiopharmaceuticals Market Size Was Valued at USD 6.13 Billion in 2022, and is Projected to Reach USD 11.0 Billion by 2030, Growing at a CAGR of 7.6% From 2023-2030.
Nuclear medicine is a specialized field within the medical domain that utilizes small amounts of radioactive materials, known as radiopharmaceuticals, to diagnose and treat diseases. Radiopharmaceuticals are compounds consisting of a radioactive substance (radionuclide) combined with a pharmaceutical agent. These substances emit gamma rays that can be detected by specialized cameras or scanners, allowing physicians to visualize and assess the functioning of organs or tissues within the body.
In this report, the nuclear medicine market has been segmented based on type, application, procedure volume and region. Based on type, the nuclear medicine market is categorized into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further segmented into alpha emitters, beta emitters, and brachytherapy isotopes. The diagnostic nuclear medicine segment is segmented into SPECT and PET.
Key Prominent Players In The Nuclear Medicine or Radiopharmaceuticals Market:
Actinium Pharmaceuticals Inc. (U.S.),Alliance Medical (U.K.),Avid Bioservices Inc(U.S.),Bayer Healthcare Pharmaceuticals (Germany),Bracco Diagnostics Inc. (Italy),Cardinal Health Inc. (U.S.),Ge Healthcare (U.S.),Ion Beam Applications S.A (Belgium),Jubilant Pharma (India),Lantheus Medical Imaging Inc. (U.S.),Medi-Radiopharma Ltd (Hungary),Nordion Inc. (Canada),Novartis/Advanced Accelerator Applications (France),Positron Corporation (U.S.),Radiopharm Theranostics Ltd. (U.S.),Curium (France),Eli Lilly And Company (U.S.),Fujifilm Toyama Chemical Co., Ltd. (Japan),Nihon Medi-Physics. Co. Ltd. (Japan),Samyoung Unitech (South Korea),Duchembio, Inc. (South Korea) and Other Major Players.
Know More About The Global Trends Impacting The Future, Download A PDF Sample@:
https://introspectivemarketresearch.com/request/15924
Market segmentation
The Nuclear Medicine or Radiopharmaceuticals market is segmented by type and application. Growth between segments over the period 2024-2032 provides accurate calculations and forecasts of revenue by type and application in terms of volume and value. This analysis can help you expand your business by targeting eligible niches.
By Product Type
· Diagnostic
· Therapeutic
By Modality
· Single-Photon Emission Computed Tomography (SPECT)
· Positron Emission Tomography (PET)
· Alpha Emitters
· Beta Emitters
· Brachytherapy
By Application
· Oncology
· Cardiology
· Neurology
By End User
· Hospitals
· Specialty Clinics
· Diagnostic Centers
Regional Analysis for COVID-19 Outbreak-Global Nuclear Medicine or Radiopharmaceuticals Market:
· North America (U.S., Canada, Mexico)
· Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
· Western Europe (Germany, U.K., France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
· Asia-Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
· Middle East & Africa (Turkey, Saudi Arabia, Bahrain, Kuwait, Qatar, UAE, Israel, South Africa)
· South America (Brazil, Argentina, Rest of SA)
Industry experts have identified key factors influencing the pace of development of the Nuclear Medicine or Radiopharmaceuticals industry, including various opportunities and gaps. A thorough analysis of the Nuclear Medicine or Radiopharmaceuticals market for the growth trends of each category makes the overall study interesting. When studying the market, researchers also dig deep into their future prospects and their contribution to the industry. Additionally, the research report evaluated the market key players and features, such as capacity utilization rate comprised of revenue.
Make An Inquiry For Report Customization (Must Use Business Contact Details For High Preference): https://introspectivemarketresearch.com/inquiry/15924
This study conducts a SWOT analysis to evaluate the strengths and weaknesses of key players in the Nuclear Medicine or Radiopharmaceuticals market. Additionally, the report performs a complex inspection of drivers and restraints operating in the market. The report also evaluates the observed trends in the parent market along with macroeconomic indicators, dominant factors and market attractiveness in relation to other segments. The report forecasts the impact of various industry aspects on the Nuclear Medicine or Radiopharmaceuticals market segments and regions.
Key Points Covered in Radiopharmaceuticals Market Study
· Market estimates and forecast 2024-2032
· Key drivers and restraints impacting market growth
· Segment-wise, Country-wise, and Region-wise Analysis
· Competition Mapping and Benchmarking
· Brand share and Market Share Analysis
· Key Radioisotope Innovations and Regulatory Climate
· COVID-19 Impact on Radiopharmaceuticals market and How to Navigate
· Recommendation on Key Winning Strategies
Purchase This Report:
https://introspectivemarketresearch.com/checkout/?user=1&_sid=15924
About us:
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assisting our clients to grow and have a successful impact on the market. Our team at IMR is ready to assist our clients to flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, that specializes in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.
Contact us:
Introspective Market Research
3001 S King Drive,
Chicago, Illinois
60616 USA
Ph no: +1-773-382-1049
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian